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ABSTRACT
Objective: To describe the use of antibiotics for
urinary tract infection (UTI) before and after surgery for
urinary incontinence (UI); and for those with use of
antibiotics before surgery, to estimate the risk of
treatment for a postoperative UTI, relative to those
without use of antibiotics before surgery.
Design: A historical population-based cohort study.
Setting: Denmark.
Participants: Women (age ≥18 years) with a primary
surgical procedure for UI from the county of Funen and
the Region of Southern Denmark from 1996
throughout 2010. Data on redeemed prescriptions of
antibiotics ±365 days from the date of surgery were
extracted from a prescription database.
Main outcome measures: Use of antibiotics for UTI
in relation to UI surgery, and the risk of being a
postoperative user of antibiotics for UTI among
preoperative users.
Results: A total of 2151 women had a primary
surgical procedure for UI; of these 496 (23.1%) were
preoperative users of antibiotics for UTI. Among
preoperative users, 129 (26%) and 215 (43.3%) also
redeemed prescriptions of antibiotics for UTI within
0–60 and 61–365 days after surgery, respectively.
Among preoperative non-users, 182 (11.0%) and 235
(14.2%) redeemed prescriptions within 0–60 and
61–365 days after surgery, respectively. Presurgery
exposure to antibiotics for UTI was a strong risk factor
for postoperative treatment for UTI, both within
0–60 days (adjusted OR, aOR=2.6 (95% CI 2.0 to 3.5))
and within 61–365 days (aOR=4.5 (95% CI 3.5 to
5.7)).
Conclusions: 1 in 4 women undergoing surgery for
UI was treated for UTI before surgery, and half of them
had a continuing tendency to UTIs after surgery. Use
of antibiotics for UTI before surgery was a strong risk
factor for antibiotic use after surgery. In women not
using antibiotics for UTI before surgery only a minor
proportion initiated use after surgery.
INTRODUCTION
Urinary tract infection (UTI) is a common
problem in women, and 40% of women have
UTI during their life-time—of these, 27%
have recurrent UTI within 12 months.1
There are several risk factors for UTI and
recurrent UTI; for example, high age, uro-
genital atrophy and urinary incontinence
(UI).2 3 UI is associated with UTI,2 4 and
UTI might be regarded as a comorbid condi-
tion in women with UI due to several factors
including poor perineal hygiene.5 Thus, it is
not surprising that UTI is seen in women
with UI, but no studies have so far examined
the burden of UTI in women undergoing
surgery for UI in a population-based setting.
It is also well known that UTI is common
after UI surgery. Risk factors of postoperative
UTI include previous recurrent UTI, post-
operative catheterisation, positive urine cul-
tures at day of surgery and preoperative
postvoid residual.6–9 UTI after UI surgery
might occur among 6–38% of the women—
depending on diagnostic methods and cri-
teria.8 10–16 and surgery-related infections
occur within 2 months.17 Thus, while some
knowledge of UTI exists in the short-term
perspective after UI surgery, there is only
little evidence on the frequency of UTI in a
more long-term perspective after UI surgery.8
The purpose of this study was to examine
the use of antibiotics for UTI before and
Strengths and limitations of this study
▪ A population-based study.
▪ 2151 included women.
▪ High quality of data sources and complete infor-
mation in the follow-up period for all included
women.
▪ Adjustment for several factors: age, procedure
type, preoperative oestrogen use, comorbidity,
educational level and personal annual income.
▪ Redeemed prescriptions were used as a proxy
for drug use.
▪ No data on symptomatology, catheter usage,
preoperative antibiotics or urine culture.
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after surgery for UI, and among women using antibiotics
for UTI before surgery to estimate the risk of post-
operative use in a short-term and long-term perspective.
This topic is clinically highly relevant in the counselling
of women prior to surgery for UI: What can they expect
of postoperative complications? Can preoperative drug
users expect to continue drug use after surgery?
MATERIALS AND METHODS
Study population and settings
Women were included in the study if they had a primary
surgical procedure for UI within the period of 1 January
1996 through 31 December 2010. Data on performed
procedures were retrieved from the Danish National
Patient Registry (NPR)18 according to codes listed in
online supplementary appendix 1. The surgical proce-
dures were performed in one of four hospitals in the
county of Funen, Denmark, between 1 January 1996 and
31 December 2006 or for the period 2007 through 2010
in 1 of 13 hospitals in the new Region of Southern
Denmark (including Funen). The extension of the area
was due to a change in the organisation of the health-
care system in 2007, including a structural change from
14 counties to 5 regions. Women with concomitant or
prior surgery for pelvic organ prolapse were included.
Women younger than 18 years were excluded.
Data sources
Data for this study were retrieved from three Danish regis-
ters: the NPR, Odense University Pharmacoepidemiologic
Database (OPED), the Statistics Denmark. All Danish citi-
zens are assigned a unique Civil Registration Number
(CRN), which enables individual-level linkage across
registries.19
The NPR contains data on discharges from public hos-
pitals in Denmark, and the completeness of recordings
has been estimated to be 99.4%.20 Information available
in the registry pertain to the CRN, the dates of admis-
sion, dates of discharge and discharge diagnoses, classi-
ﬁed according to the International Classiﬁcation of
Diseases-8 (ICD-8) (1977–1993) and ICD-10 (1994 and
onward)21 22 as well as codes from the Danish classiﬁca-
tion system of surgical procedures.23
Information on relevant drugs (antibiotics and oestro-
gens) was retrieved from the OPED for the period 1995
to 2011 for the entire study population.
The OPED is pharmacy-based and captures all reim-
bursed prescriptions, and contains person-identiﬁable
data with complete coverage on all computerised pre-
scription reimbursements from the county of Funen
(population 2006: 479 000) from 1990 and from January
2007 onwards extended to the whole Region of
Southern Denmark (population 1.2 million). The age
and gender distribution of this population are very
similar to that of the Danish population as a whole
(2006: 5.4 million), and the prescribing of drugs is very
similar to the national average.24
Prescription reimbursements are given independent
of patient income to all legal inhabitants of Denmark as
a part of the National Health Service. Each record
includes the CRN, date of purchase, a full account of
what have been dispensed, including the brand name
and the Anatomical Therapeutic Chemical (ATC) classi-
ﬁcation code. Information not included in the prescrip-
tion database is drugs sold over the counter or drugs not
reimbursed by the county authority (mainly oral contra-
ceptives, sedatives and hypnotics). Data on highest
attained educational level and annual income were
retrieved from the Danish Integrated Database for
Labour Market Research at Statistics Denmark, a data-
base with annually updated socioeconomic data for each
Danish citizen, mainly supplied by tax authorities, edu-
cational institutions and employment services.25
Antibiotics under study
Included drugs were antibiotics traditionally used in
Denmark exclusively or predominantly for the treatment
of UTI (sulphamethizole (ATC J01EB02), pivmecillinam
(ATC J01CA08), nitrofurantoin (ATC J01XE01), tri-
methoprim (ATC J01EA01), as well as mecillinam (ATC
J01CA11))26 27 and with a duration of 3–5 days. The
indications for the prescribed drugs are not registered
in the OPED; therefore, pivampicillin and amoxicillin
were not included—as these antibiotics are also com-
monly used in treatment of upper respiratory tract infec-
tions. Likewise, broader spectrum antibiotics such as
cephalosporins and quinolones were not included, as
they are not commonly used for UTIs in Denmark.
Exposed and unexposed cohorts
Exposed cohort: All women ≥18 years undergoing a
primary surgical procedure for UI between 1 January
1996 and 31 December 2010 in the county of Funen/
Region of Southern Denmark, and having redeemed
one or more prescriptions on antibiotics within 365 days
preceding the date of surgery (index date).
Unexposed cohort: All women ≥18 years undergoing
a primary surgical procedure for UI between 1 January
1996 and 31 December 2010 in the county of Funen/
Region of Southern Denmark without having redeemed
similar prescriptions within the same time frame.
Outcome data
For both exposed and unexposed women, the outcome
was use of antibiotics for UTI, deﬁned as having
redeemed at least one prescription for these antibiotics
within (1) 60 days after the index date (short-term post-
operative users) and (2) 61–365 days after the index
date (long-term postoperative users). These outcomes
were not mutually exclusive, that is, a woman might be
classiﬁed as a short-term and long-term user,
postoperatively.
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Covariates
The use of antibiotics might be affected by age, type of
surgery, use of oestrogen, comorbidity, calendar time
and the individuals’ ability to pay for the medicine
might be affected by educational level and annual
income. Therefore, these variables were included in the
analysis as potential confounders.
Type of procedures
The types of UI surgery were divided into four groups
according to the surgical procedure code: (1) mid-
urethral sling procedures with transobturator route
(toMUS), (2) mid-urethral sling procedures with retro-
pubic route (rpMUS), (3) bulking procedures and (4)
other types of UI surgeries.
Oestrogen
Use of oestrogens (ATC G03C) was included in the ana-
lyses as a confounder.
To adjust for preoperative oestrogen use, preoperative
users of oestrogens were deﬁned as women who had
redeemed at least one prescription for oestrogens within
365 days preceding the date of surgery and nonusers
were deﬁned as those who had no preoperative oestro-
gen use during the same period. The local and systemic
oestrogens were included.
Comorbidity
The comorbidity was classiﬁed according to the vali-
dated, well-known and widely used Charlson comorbidity
index (CCI),28–31 which assigns different weights (1, 2, 3
and 6) to 20 different disease categories speciﬁed by
medical condition and severity (eg, diabetes, cardiovascu-
lar diseases, chronic pulmonary, renal, liver and connect-
ive tissue diseases). The CCI was computed based on each
woman’s complete hospital discharge history from the
NPR since 1977. A categorised version of the CCI score
values was used: 0 (low), 1–2 (medium) and 3+ (high).32
Education and income
Information on educational level and annual income for
each woman was retrieved as a measure of socio-
economic status. Educational level was categorised
according to the highest attained educational level in the
year of surgery: ‘Basic’ (basic school/high school educa-
tion: 7–12 years of primary, secondary and grammar
school education), ‘Secondary’ (vocational education,
10–12 years of education) and ‘Higher’ (a university
degree or an examination in another higher institution
requiring an average total of 13 years or more).28
On the basis of quartiles of annual income for each
woman in the year of her surgery, we categorised women
in low (1st quartile), medium (2nd and 3rd quartile)
and high income (4th quartile).
Statistical analysis
The use of antibiotics for UTI within the ﬁrst 365 days
after surgery for exposed and unexposed cohorts was
illustrated in a ﬂow chart. We also constructed contin-
gency tables for the main study variables, and computed
ORs, with 95% CIs.
To analyse the signiﬁcance of preoperative antibiotic
use as risk factor of postoperative use (within 60 days
and within 61–365 days after surgery), adjusted ORs
were estimated by means of multivariate logistic regres-
sion models.
Adjustment was made for age (18–39, 40–59 and
≥60 years (reference)), type of procedures (toMUS (ref-
erence), rpMUS, bulking, others), education (basic (ref-
erence), secondary, higher), annual income (low
(reference), middle, high), comorbidity (CCI 0 (refer-
ence), CCI 1–2, CCI 3+), calendar year (1996–2006,
2007–2008 (reference), 2009–2010) and use of oestro-
gen within 365 days preceding the date of surgery (no
(reference), yes).
Stratiﬁed analyses were performed according to the
use of oestrogens before surgery to examine the associ-
ation between the use of antibiotics for UTI in oestrogen
users versus oestrogen non-users.
All analyses were performed using Stata Release
V.12.0.
RESULTS
A total of 2151 women had a primary surgical procedure
for UI between 1 January 1996 and 31 December 2010;
2073 had a solitary UI surgery, and 78 had concomitant
surgery for pelvic organ prolapse.
Of the 2151 women, 1655 (76.9%) women did not use
antibiotics for UTI within 365 days preceding the date of
surgery, while 496 (23.1%) did, and the majority (376/
496=75.8%) redeemed ≤2 prescriptions preoperatively
and only a minority (42/496=8%) redeemed more than
ﬁve or more prescriptions. The use of antibiotics for
UTI within 365 days after surgery is detailed for the
exposed and unexposed cohorts in ﬁgure 1. The most
commonly used antibiotics both preoperatively and post-
operatively were sulphamethizol and pivmecillinam.
Women having redeemed prescriptions for antibiotics for
UTI before surgery (exposed)
Of the 496 women with prior use of antibiotics for UTI,
129 (26%) redeemed a prescription for antibiotics for
UTI within 0–60 days after surgery, and of these, 85
(65.9%) also within 61–365 days after surgery (ﬁgure 1).
A total of 215 (43.3%) continued to redeem prescrip-
tions for antibiotics within 61–365 days (ﬁgure 1).
Women with no usage of antibiotics for UTI before surgery
(unexposed)
Of the 1655 women who did not redeem prescription
before surgery, 182 (11%) women had a short-term use
of antibiotics for UTI after surgery; and of these,
64 women were also long-term users (ﬁgure 1). Among
unexposed without short-term postoperative use of anti-
biotics, 171 (10.3%) became long-term postoperative
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users (ﬁgure 1). The total number of women with long-
term antibiotic use was 235 (14.2%).
Comparison of exposed and unexposed cohorts
Baseline characteristics of exposed and unexposed
women are presented in table 1. The most commonly
used procedure was to MUS accounting for approxi-
mately half of the procedures performed in both the
exposed and the unexposed group. The most commonly
prescribed drugs prior to surgery were sulphamethizol
and pivmecillinam. Compared with unexposed women,
exposed women tended to be older, to be more frequent
oestrogen users and to have higher comorbidity indices.
There was no difference in educational level or personal
annual income.
The unadjusted OR of a prior antibiotic user being a
postoperative short-term and long-term user was 2.8
(95% CI 2.2 to 3.7) and 4.6 (95% CI 3.7 to 5.8), respect-
ively. The adjusted OR of being short-term and long-
term user of antibiotics for UTI after surgery was 2.6
(95% CI 2.0 to 3.5) and 4.5 (95% CI 3.5 to 5.7), respect-
ively (table 2). Thus, adjustment for confounders did vir-
tually not change the relative risk estimates. The details
from logistic regression models are presented in table 2
showing the impact of each prognostic factor included.
Regarding short-term use, the strongest risk factors were
procedure types (rpMUS/others), high comorbidity
index and preoperative antibiotic use. Preoperative use
of antibiotics for UTI was the strongest risk factor of
long-term postoperative use.
Stratiﬁed analyses according to the use of oestrogens
before surgery showed that among users of oestrogen,
the adjusted OR for short-term and long-term use of
antibiotics for UTI after surgery increased to 3.3 (95%
CI 2.3 to 4.8) and 5.2 (95% CI 3.7 to 7.3), respectively,
table 3.
DISCUSSION
Among 2151 women undergoing surgery for UI, nearly
one-fourth had redeemed at least one prescription of
antibiotics for UTI preoperatively, and among preopera-
tive users nearly half of the women also redeemed pre-
scriptions of antibiotics for UTI within 61–365 days after
surgery. Among preoperative users of antibiotics we
found a 2–3-fold increased risk of short-term use of anti-
biotics for UTI after surgery, and a 4–5-fold increased
risk of being long-term user. In women not using anti-
biotics for UTI before surgery only a minor proportion
initiated use of antibiotics after surgery.
To ensure that our results were not inﬂuenced by
effect modiﬁcation of oestrogen use we stratiﬁed our
analyses for preoperative use of oestrogen. In both strata
we found an increased risk of postoperative antibiotic
use for the exposed women. The risk estimates for short-
term and long-term use were, however, higher among
women using oestrogen preoperatively compared with
women without prior oestrogen use.
The proportion of women with concomitant surgery
for pelvic organ prolapse in our cohort of women with
UI surgery was low, and this was as expected given the
current practice in Scandinavia with a conservative
approach of addressing the predominant problem of
either pelvic organ prolapse or UI in sequential
surgery.33 Thus, our results were not inﬂuenced by a
mixed cohort with both UI surgery and pelvic organ
prolapse surgery.
Our study has several strengths: (1) it is population-
based in the sense that this study covers all the relevant
surgeries in a well-deﬁned geographic area in Denmark,
(2) the source of procedure codes in the NPR has high
coverage and validity—the NPR records 99.4% of all dis-
charges from hospitals in Denmark, and the procedures
in the NRP have been validated showing a high quality of
the data with positive predictive values of 94–100%,34–36
Figure 1 Women (N=2151) with primary surgery for urinary incontinence (UI) and their use of antibiotics for urinary tract
infection before and after surgery for UI. Exposed women had redeemed one or more prescriptions of antibiotics within 365 days
preceding the date of surgery. Unexposed women had not redeemed prescriptions of antibiotics within 365 days preceding the
date of surgery.
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(3) the access to high-quality data on prescriptions
from the OPED that are representative for the Danish
population,24 (4) information on several confounders
such as comorbidity and socioeconomic status, (5) com-
plete information on the follow-up period for all
included women, (6) outcome data on postoperative
antibiotic prescriptions are recorded independently of
prior antibiotic use, thus preventing differential mis-
classiﬁcation of the outcome, (7) the antibiotics
included in this study are UTI speciﬁc and are drugs of
choice in Denmark for treating UTI and ﬁnally (8) the
surgical procedures included have no other indications
than UI, which strongly limits the number of alternative
interpretations of our ﬁndings. Furthermore, the exclu-
sion of antibiotics with other indications than UTI may
even have led to an underestimation of the risk of UTI.
There are possible limitations to our study. We have
no information on perioperative use of antibiotic, anti-
biotic given while the patient was still hospitalised, or
results of urine culture. A redeemed prescription of anti-
biotics for UTI does not necessarily equal a UTI, and
urine culture is not always performed prior to a prescrip-
tion. Thus, empiric therapy is possible. To prevent UTI
and other postoperative infections a perioperative single-
dose of intravenous antibiotic is often used in
Denmark.37 However, perioperative antibiotic use is
unlikely to be much different between exposed and
unexposed cohorts and will thus not bias our relative
risk estimates. In the short-term perspective after surgery
we had no knowledge of postoperative catheter usage
which is a limitation, especially since postoperative UTI
is associated with catheter usage in the postoperative
period,38 39 but again we have no reasons to believe that
use of catheters differed among exposed and unexposed
cohorts. We were not able to control for all potential
confounders such as body mass index, parity, intraopera-
tive bladder perforation or precise menopausal status,
but the importance of these factors for the association
examined in this study is not clear. We had no data on
patient symptomatology, that is, whether stress UI,
urgency UI, mixed UI or overactive bladder syndrome
were predominant, or on urodynamic study, and it could
have been interesting to further examine the users of
UTI antibiotics (both before and after surgery) accord-
ing to the type of UI symptomatology.
It is surprising that among women using antibiotics
for UTIs before UI surgery, half of them have a continu-
ing tendency to use these antibiotics after surgery. This
is not explained by recurrent UI surgery in the study
period of 1 year after surgery as only approximately 5%
of women experienced a new surgery in our population.
Possible explanations for the continuing tendency to
UTI could be a genetic predisposition for UTI, an ana-
tomic predisposition for UTI, or an increased awareness
of UTI for both the women and their doctor.
On the basis of the ﬂow chart in our study, we
observed a tendency to continuing UTI among women
with preoperative antibiotic use in short-term and long-
term, postoperatively. To our knowledge, this is the
largest, and only population-based, study examining the
use of antibiotics for UTI in relation to surgery for UI
and addressing the risk of short-term and long-term
postoperative use of antibiotics for UTI among women
with preoperative UTI. In addition, our study provides
knowledge about which other factors than preoperative
Table 1 Baseline characteristics of all included women
(N=2151) having a primary surgical procedure for UI in
Denmark, 1996–2010
Exposed*
n=496
Unexposed†
n=1655
Mean age (±SD), years (at
time of first UI surgery)
60.2 (±13.2) 54.2 (±12.4)
Age groups, n (%)
18–39 30 (6.1) 182 (11.0)
40–59 196 (39.5) 911 (55.1)
60− 270 (54.4) 562 (33.9)
Procedures, n (%)
rpMUS 140 (28.2) 535 (32.3)
toMUS 222 (44.8) 750 (45.3)
Bulking 110 (22.2) 250 (15.1)
Others 24 (4.8) 120 (7.3)
Concomitant prolapse
surgery, n (%)
12 (2.4) 66 (4.0)
Antibiotics before surgery, n (%)‡
Sulfamethizol—J01EB02 299 (60.3) –
Pivmecillinam—J01CA08 288 (58.1) –
Nitrofurantoin—J01XE01 65 (13.1) –
Trimethoprim—J01EA01 45 (9.1) –
Mecillinam—J01CA11 0 (0) –
Oestrogen users, n (%)§
No 211 (42.5) 997 (60.2)
Yes 285 (57.5) 658 (39.8)
Comorbidity (CCI), n (%)
0 298 (60.1) 1214 (73.4)
1–2 139 (28.0) 381 (23.0)
3+ 59 (11.9) 60 (3.6)
Educational level, n (%)¶
Basic 229 (47.4) 688 (42.3)
Secondary 170 (35.2) 600 (36.8)
Higher 84 (17.4) 340 (20.9)
Annual income, n (%)
Low (1st quartile) 152 (30.7) 385 (23.3)
Middle (2nd–3rd quartile) 252 (50.8) 825 (49.9)
High (4th quartile) 92 (18.5) 445 (26.9)
Year of surgery n (%)
1996–2006 106 (21.4) 353 (21.3)
2007–2008 186 (37.5) 605 (36.6)
2009–2010 204 (41.1) 697 (42.1)
*Exposed women had redeemed one or more prescriptions of
antibiotics within 365 days preceding the date of surgery.
†Unexposed women had not redeemed prescriptions of antibiotics
within 365 days preceding the date of surgery.
‡Does not sum up to 100%. Some women redeemed more than
one type of the drugs during the time period.
§Women with at least one redeemed prescription of oestrogen
within 365 days preceding the date of surgery.
¶Unknown highest attained educational level: 40 women.
CCI, Charlson comorbidity index; rpMUS, retropubic mid-urethral
sling, toMUS, trans-obturator mid-urethral sling.
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antibiotic were important for postoperative antibiotic
use for UTI. We found that for short-term use procedure
type (rpMUS, others), and high comorbidity were risk
factors and for long-term use high comorbidity was a
risk factor. Our study also showed that educational level
and personal income did not seem to inﬂuence the risk
of postoperative antibiotic use.
In Denmark, dipstick urine test is a part of the preopera-
tive examination, and surgeons might feel encouraged to
treat the women with antibiotics prior to surgery based on
dipstick urine test without symptoms or urine culture in an
attempt to try to minimise the risk of postoperative UTI.
According to the Danish Programme for the surveil-
lance of antimicrobial consumption and resistance in
bacteria from animals, food and humans, the resistance,
especially in bacteria other than Escherichia coli, has
increased during the last years. E coli is the most fre-
quent cause of UTIs both in community-acquired and
hospital-acquired UTIs.
Our study calls for further studies within this area—
studies examining UTI before and after surgery accord-
ing to different types of UI (stress UI, urgency UI,
mixed UI), UTI in relation to surgery in especially post-
menopausal women, issues regarding recurrent UTI and
UI surgery, and if prophylactic antibiotic use (periopera-
tive intravenous/prolonged oral antibiotics) could
reduce the risk of postoperative UTI after UI surgery in
a short-term and long-term perspective. Furthermore, it
would be interesting to assess the use of similar antibio-
tics in the background population of women to examine
whether there is an increased antibiotic burden asso-
ciated with surgery for UI.
In conclusion, we found that one in four women
undergoing surgery for UI was treated for UTI before
surgery, and half of these women continued the ten-
dency of UTI after surgery. In women not using antibio-
tics for UTI before surgery only a minor proportion
initiated use of antibiotics for UTI after surgery. The
Table 2 Risk factors of postoperative use of antibiotics
Postoperative
non-use
Postoperative short-term
use
Postoperative
non-use
Postoperative long-term
use
Number Number OR (95% CI) Number Number OR (95% CI)
Preoperative use
No 1473 182 Reference 1420 235 Reference
Yes 367 129 2.6 (2.0 to 3.5) 281 215 4.5 (3.5 to 5.7)
Age group
18–39 185 27 0.9 (0.5 to 1.5) 163 49 1.5 (0.9 to 2.3)
40–59 981 126 0.6 (0.5 to 0.9) 931 176 0.7 (0.5 to 0.9)
60− 674 158 Reference 607 225 Reference
Procedure
rpMUS 568 107 1.7 (1.1 to 2.7) 529 146 1.3 (0.9 to 1.9)
toMUS 849 123 Reference 782 190 Reference
Bulking 315 45 1.4 (0.9 to 2.0) 278 82 1.1 (0.8 to 1.5)
Others 108 36 3.1 (1.6 to 5.9) 112 32 1.5 (0.8 to 2.8)
Preoperative use of oestrogen*
No 1059 149 Reference 992 216 Reference
Yes 781 162 1.2 (0.9 to 1.6) 709 234 1.2 (0.9 to 1.5)
Comorbidity (CCI)
0 1328 184 Reference 1241 271 Reference
1–2 425 95 1.5 (1.1 to 2.0) 384 136 1.4 (1.1 to 1.8)
3+ 87 32 3.1 (1.6 to 5.9) 76 43 1.5 (1.0 to 2.4)
Educational level†
Basic 775 142 Reference 702 215 Reference
Secondary 665 105 1.1 (0.8 to 1.5) 623 147 1.0 (0.7 to 1.1)
Higher 362 62 1.3 (0.9 to 2.0) 342 82 0.9 (0.6 to 1.3)
Annual income
Low 434 103 Reference 404 133 Reference
Middle 930 147 0.9 (0.6 to 1.2) 847 230 1.0 (0.8 to 1.3)
High 476 61 0.9 (0.6 to 1.4) 450 87 0.9 (0.6 to 1.3)
Year of surgery
1996–2006 363 96 1.4 (0.9 to 2.2) 352 107 0.9 (0.7 to 1.1)
2007–2008 692 99 Reference 628 163 reference
2009–2010 785 116 1.0 (0.8 to 1.4) 721 180 1.0 (0.8 to 1.4)
Results from multivariate logistic regression models on (1) short-term (0–60 days after surgery) and (2) long-term (61–356 days after
surgery).
*Women with at least one redeemed prescription of oestrogen within 365 days preceding the date of surgery.
†Unknown highest attained educational level: 40 women.
CCI, Charlson comorbidity index; Post op, postoperative; rpMUS, retropubic mid-urethral sling; toMUS, trans-obturator mid-urethral sling.
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strongest risk factor of postoperative use of antibiotics
for UTI was the use of these antibiotics before surgery.
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